RA
AMRX icon

Rise Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Rise Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$4.16K – 1124
2024
Q3 		$4.16K Hold
500
– – ﹤0.01% 1091
2024
Q2 		$3.17K Hold
500
– – ﹤0.01% 1097
2024
Q1 		$3.03K Hold
500
– – ﹤0.01% 1116
2023
Q4 		$3.04K Hold
500
– – ﹤0.01% 426
2023
Q3 		$2.11K Hold
500
– – ﹤0.01% 460
2023
Q2 		$1.55K Hold
500
– – ﹤0.01% 543
2023
Q1 		$695 Hold
500
– – ﹤0.01% 702
2022
Q4 		$995 Hold
500
– – ﹤0.01% 650
2022
Q3 		$1K Hold
500
– – ﹤0.01% 593
2022
Q2 		$2K Hold
500
– – ﹤0.01% 533
2022
Q1 		$2K Hold
500
– – ﹤0.01% 515
2021
Q4 		$2.4K Buy
+500
New +$2.49K ﹤0.01% 508

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return